Literature DB >> 31489431

Blood pressure goal attainment in multi-ethnic Asian patients with hypertension and dyslipidaemia in primary care.

Kim Hwee Koh1,2, Chin Chin Goh3, Soo Chye Paul Goh4, Yi Ling Eileen Koh5, Ngiap Chuan Tan5.   

Abstract

INTRODUCTION: Hypertension and dyslipidaemia are major risk factors for cardiovascular diseases and achieving treatment goals mitigates such risks. This study determined demographic and medication-related factors associated with blood pressure (BP) goal attainment in patients with concomitant hypertension and dyslipidaemia.
METHODS: This paper is a sub-analysis of the Lipid HEALTH study, a questionnaire survey focusing on adult Asian patients with both dyslipidaemia and hypertension. An interviewer-administered questionnaire was used to obtain demographic and clinical information. Laboratory and prescription data was retrieved from electronic health records. BP goals were defined by international guidelines. Data was audited and analysed, and logistic regression analysis was used to identify factors determining BP goal attainment.
RESULTS: Among the 851 included patients, 49.7% attained their BP goals. 37.0% were on monotherapy, 57.6% on ≥ 2 BP-lowering medications, and 5.4% had no pharmacologic treatment. Among those on pharmacotherapy, 51.2% failed to achieve BP goals. Calcium channel blockers were the most frequently prescribed medications. Attainment of BP goals was significantly associated with: not having Type 2 diabetes mellitus (odds ratio [OR] 2.27, 95% confidence interval [CI] 1.61-3.13); attaining low-density lipoprotein cholesterol goal (OR 2.02, 95% CI 1.45-2.81); being solely on dietary control (OR 2.19, 95% CI 1.09-4.39); and receiving monotherapy (OR 1.71, 95% CI 1.18-2.48).
CONCLUSION: BP treatment goals were attained by half of the patients with dyslipidaemia and hypertension, and half of those on pharmacotherapy. Type 2 diabetes mellitus and low-density lipoprotein cholesterol control were significantly associated with BP goal attainment. Copyright: © Singapore Medical Association.

Entities:  

Keywords:  blood pressure; dyslipidaemia; hypertension; treatment goal

Year:  2019        PMID: 31489431     DOI: 10.11622/smedj.2019102

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  3 in total

1.  Adapting and embracing change in the new normal.

Authors:  Tiing Leong Ang; Kian Keong Poh
Journal:  Singapore Med J       Date:  2021-01       Impact factor: 1.858

2.  Comparing and determining factors associated with hypertension self-care profiles of patients in two multi-ethnic Asian countries: cross-sectional studies between two study populations.

Authors:  Sabrina Yi-Mei Wee; Hani Salim; Maliza Mawardi; Yi Ling Eileen Koh; Hanifatiyah Ali; Sazlina Shariff Ghazali; Ping Yein Lee; Siew Mooi Ching; Nurainul Hana Shamsuddin; Ngiap Chuan Tan
Journal:  BMJ Open       Date:  2021-06-14       Impact factor: 2.692

3.  High Blood Pressure-A High Risk Problem for Public Healthcare.

Authors:  A M Brașoveanu; M S Șerbănescu; D N Mălăescu; O I Predescu; B V Cotoi
Journal:  Curr Health Sci J       Date:  2019-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.